ARCHIVES

Gynecologic Oncology Group To Conduct Phase III Trial of Xyotax For Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 4 | April 30, 2004

Download PDF Visit The Full Archive

Related Articles

Phase III Nexavar Trial Fails Primary Endpoint

August 29, 2014

NCI CTEP Approved Trials For the Month of August

August 30, 2013

In Brief: Bast To Head M.D. Anderson Medicine Dib.; Ozer Named Emory Cancer Center Director

April 8, 1994

Natcher: Multiple Year Funding Would Not be Approved If Presented As Request For Reprogramming

March 22, 1985

Appropriators Project 1.2% Increase for NIH, Due to Budget Plan

June 20, 1997

Triple-Negative Breast Cancer Increases With Number of Births

March 25, 2011